Literature DB >> 28540412

A distal auxiliary element facilitates cleavage and polyadenylation of Dux4 mRNA in the pathogenic haplotype of FSHD.

Natoya Peart1,2,3, Eric J Wagner4.   

Abstract

The degenerative muscle disorder facioscapulohumeral dystrophy (FSHD) is thought to be caused by the inappropriate expression of the Double Homeobox 4 (Dux4) protein in muscle cells leading to apoptosis. Expression of Dux4 in the major form of FSHD is a function of two contributing molecular changes: contractions in the D4Z4 microsatellite repeat region where Dux4 is located and an SNP present within a region downstream of the D4Z4. This SNP provides a functional, yet non-consensus polyadenylation signal (PAS) is used for the Dux4 mRNA 3' end processing. Surprisingly, the sequences flanking the Dux4 PAS do not resemble a typical cleavage and polyadenylation landscape with no recognizable downstream sequence element and a suboptimal cleavage site. Here, we conducted a systematic analysis of the cis-acting elements that govern Dux4 cleavage and polyadenylation. Using a transcriptional read-through reporter, we determined that sequences downstream of the SNP located within the β-satellite region are critical for Dux4 cleavage and polyadenylation. We also demonstrate the feasibility of using antisense oligonucleotides to target these sequences as a means to reduce Dux4 expression. Our results underscore the complexity of the region immediately downstream of the D4Z4 and uncover a previously unknown function for the β-satellite region in Dux4 cleavage and polyadenylation.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28540412     DOI: 10.1007/s00439-017-1813-8

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  39 in total

1.  Increased efficiency of mRNA 3' end formation: a new genetic mechanism contributing to hereditary thrombophilia.

Authors:  N H Gehring; U Frede; G Neu-Yilik; P Hundsdoerfer; B Vetter; M W Hentze; A E Kulozik
Journal:  Nat Genet       Date:  2001-08       Impact factor: 38.330

2.  Genomic analysis of human chromosome 10q and 4q telomeres suggests a common origin.

Authors:  Michel van Geel; Morag C Dickson; Amy F Beck; Daniel J Bolland; Rune R Frants; Silvère M van der Maarel; Pieter J de Jong; Jane E Hewitt
Journal:  Genomics       Date:  2002-02       Impact factor: 5.736

3.  Contractions of D4Z4 on 4qB subtelomeres do not cause facioscapulohumeral muscular dystrophy.

Authors:  Richard J F L Lemmers; Mariëlle Wohlgemuth; Rune R Frants; George W Padberg; Eva Morava; Silvere M van der Maarel
Journal:  Am J Hum Genet       Date:  2004-10-04       Impact factor: 11.025

4.  Molecular architecture of the human pre-mRNA 3' processing complex.

Authors:  Yongsheng Shi; Dafne Campigli Di Giammartino; Derek Taylor; Ali Sarkeshik; William J Rice; John R Yates; Joachim Frank; James L Manley
Journal:  Mol Cell       Date:  2009-02-13       Impact factor: 17.970

Review 5.  Delineating the structural blueprint of the pre-mRNA 3'-end processing machinery.

Authors:  Kehui Xiang; Liang Tong; James L Manley
Journal:  Mol Cell Biol       Date:  2014-03-03       Impact factor: 4.272

6.  Gain-of-function reporters for analysis of mRNA 3'-end formation: Design and optimization.

Authors:  Natoya Peart; Eric J Wagner
Journal:  Biotechniques       Date:  2016-03-01       Impact factor: 1.993

7.  Cleavage site determinants in the mammalian polyadenylation signal.

Authors:  F Chen; C C MacDonald; J Wilusz
Journal:  Nucleic Acids Res       Date:  1995-07-25       Impact factor: 16.971

8.  A functionally redundant downstream sequence in SV40 late pre-mRNA is required for mRNA 3'-end formation and for assembly of a precleavage complex in vitro.

Authors:  D Zarkower; M Wickens
Journal:  J Biol Chem       Date:  1988-04-25       Impact factor: 5.157

9.  Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity.

Authors:  Federica Barzaghi; Laura Passerini; Rosa Bacchetta
Journal:  Front Immunol       Date:  2012-07-31       Impact factor: 7.561

10.  Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy.

Authors:  Giulia Ricci; Isabella Scionti; Francesco Sera; Monica Govi; Roberto D'Amico; Ilaria Frambolli; Fabiano Mele; Massimiliano Filosto; Liliana Vercelli; Lucia Ruggiero; Angela Berardinelli; Corrado Angelini; Giovanni Antonini; Elisabetta Bucci; Michelangelo Cao; Jessica Daolio; Antonio Di Muzio; Rita Di Leo; Giuliana Galluzzi; Elisabetta Iannaccone; Lorenzo Maggi; Valerio Maruotti; Maurizio Moggio; Tiziana Mongini; Lucia Morandi; Ana Nikolic; Ebe Pastorello; Enzo Ricci; Carmelo Rodolico; Lucio Santoro; Maura Servida; Gabriele Siciliano; Giuliano Tomelleri; Rossella Tupler
Journal:  Brain       Date:  2013-09-11       Impact factor: 13.501

View more
  8 in total

Review 1.  The evolution of DUX4 gene regulation and its implication for facioscapulohumeral muscular dystrophy.

Authors:  Sujatha Jagannathan
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2022-02-11       Impact factor: 6.633

Review 2.  Current Therapeutic Approaches in FSHD.

Authors:  Leo H Wang; Rabi Tawil
Journal:  J Neuromuscul Dis       Date:  2021

3.  Transgenic mice expressing tunable levels of DUX4 develop characteristic facioscapulohumeral muscular dystrophy-like pathophysiology ranging in severity.

Authors:  Takako I Jones; Guo-Liang Chew; Pamela Barraza-Flores; Spencer Schreier; Monique Ramirez; Ryan D Wuebbles; Dean J Burkin; Robert K Bradley; Peter L Jones
Journal:  Skelet Muscle       Date:  2020-04-11       Impact factor: 4.912

4.  Systemic antisense therapeutics inhibiting DUX4 expression ameliorates FSHD-like pathology in an FSHD mouse model.

Authors:  Ngoc Lu-Nguyen; Alberto Malerba; Shan Herath; George Dickson; Linda Popplewell
Journal:  Hum Mol Genet       Date:  2021-07-09       Impact factor: 6.150

5.  A cre-inducible DUX4 transgenic mouse model for investigating facioscapulohumeral muscular dystrophy.

Authors:  Takako Jones; Peter L Jones
Journal:  PLoS One       Date:  2018-02-07       Impact factor: 3.240

6.  Functional domains of the FSHD-associated DUX4 protein.

Authors:  Hiroaki Mitsuhashi; Satoshi Ishimaru; Sachiko Homma; Bryant Yu; Yuki Honma; Mary Lou Beermann; Jeffrey Boone Miller
Journal:  Biol Open       Date:  2018-04-26       Impact factor: 2.422

Review 7.  Targeting the Polyadenylation Signal of Pre-mRNA: A New Gene Silencing Approach for Facioscapulohumeral Dystrophy.

Authors:  Anne-Charlotte Marsollier; Romain Joubert; Virginie Mariot; Julie Dumonceaux
Journal:  Int J Mol Sci       Date:  2018-05-03       Impact factor: 5.923

Review 8.  Consequences of epigenetic derepression in facioscapulohumeral muscular dystrophy.

Authors:  Anna Greco; Remko Goossens; Baziel van Engelen; Silvère M van der Maarel
Journal:  Clin Genet       Date:  2020-03-04       Impact factor: 4.438

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.